Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LAG3 Protein (AA 23-222) (His-IF2DI Tag)

LAG3 Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant Greater than 95 % by SDS-PAGE gel analyses WB, ELISA
N° du produit ABIN7123802
  • Antigène Voir toutes LAG3 Protéines
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 23-222
    Origine
    • 18
    • 11
    • 6
    • 4
    • 1
    • 1
    • 1
    Humain
    Source
    • 21
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette LAG3 protéine est marqué à la His-IF2DI Tag.
    Application
    Western Blotting (WB), ELISA
    Pureté
    Greater than 95 % by SDS-PAGE gel analyses
    Stérilité
    0.2 μm filtered
    Top Product
    Discover our top product LAG3 Protéine
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in PBS with 5 % trehalose, pH 7.4
    Stock
    4 °C,-20 °C
    Stockage commentaire
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Date de péremption
    12 months
  • Antigène
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Autre désignation
    CD223 (LAG3 Produits)
    Synonymes
    CD223 Protein, LAG-3 Protein, Ly66 Protein, lymphocyte activating 3 Protein, lymphocyte-activation gene 3 Protein, LAG3 Protein, Lag3 Protein
    Sujet
    CD223, CD223 antigen, FDC protein, LAG-3, Lag3, LAG3_HUMAN, Lymphocyte activating 3, Lymphocyte activation gene 3, Lymphocyte activation gene 3 protein, Protein FDC
    Poids moléculaire
    42.5 kDa
    UniProt
    P18627
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici: